| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |